Literature DB >> 10886621

Adhesion of inactivated probiotic strains to intestinal mucus.

A C Ouwehand1, S Tölkkö, J Kulmala, S Salminen, E Salminen.   

Abstract

It has been suggested that probiotics should be viable in order to elicit beneficial health effects. Inactivation of probiotics has been suggested to interfere with the binding to the mucosa and thereby with the immune modulating activity of probiotics. The effect of different inactivation methods on the mucus adhesion of nine probiotic strains was studied. Inactivation by heat or gamma-irradiation generally decreased the adhesive abilities. However, heat treatment increased the adhesion of Propionibacterium freudenreichii and gamma-irradiation enhanced the adhesion of Lactobacillus casei Shirota. Inactivation by u.v. was not observed to modulate the adhesion of the tested strains and it was concluded to be the most appropriate method for studying non-viable probiotics and preparing control products.

Entities:  

Mesh:

Year:  2000        PMID: 10886621     DOI: 10.1046/j.1472-765x.2000.00773.x

Source DB:  PubMed          Journal:  Lett Appl Microbiol        ISSN: 0266-8254            Impact factor:   2.858


  25 in total

1.  Development of a flow cytometric method to analyze subpopulations of bacteria in probiotic products and dairy starters.

Authors:  Christine J Bunthof; Tjakko Abee
Journal:  Appl Environ Microbiol       Date:  2002-06       Impact factor: 4.792

Review 2.  Multifaceted attributes of dairy propionibacteria: a review.

Authors:  Sarang Dilip Pophaly; Sudhir Kumar Tomar; Sachinandan De; Rameshwar Singh
Journal:  World J Microbiol Biotechnol       Date:  2012-07-05       Impact factor: 3.312

3.  MMP7 Modulation by Short- and Long-term Radiotherapy in Patients with Rectal Cancer.

Authors:  Christina Stene; Andrea Polistena; Alexander Gaber; Björn Nodin; Bianca Ottochian; Diya Adawi; Nicola Avenia; Karin Jirström; Louis Banka Johnson
Journal:  In Vivo       Date:  2018 Jan-Feb       Impact factor: 2.155

4.  Cell surface and extracellular proteins of potentially probiotic Lactobacillus reuteri as an effective mediator to regulate intestinal epithelial barrier function.

Authors:  Tejinder P Singh; Nimisha Tehri; Gurpreet Kaur; Ravinder K Malik
Journal:  Arch Microbiol       Date:  2021-04-08       Impact factor: 2.552

5.  Purification and characterization of a surface protein from Lactobacillus fermentum 104R that binds to porcine small intestinal mucus and gastric mucin.

Authors:  Maurilia Rojas; Felipe Ascencio; Patricia L Conway
Journal:  Appl Environ Microbiol       Date:  2002-05       Impact factor: 4.792

6.  Lactobacillus rhamnosus ingestion promotes innate host defense in an enteric parasitic infection.

Authors:  Jessica McClemens; Janice J Kim; Huaqing Wang; Yu-Kang Mao; Matthew Collins; Wolfgang Kunze; John Bienenstock; Paul Forsythe; Waliul I Khan
Journal:  Clin Vaccine Immunol       Date:  2013-03-27

7.  Intestinal mucus alters the ability of probiotic bacteria to bind aflatoxin B1 in vitro.

Authors:  S Gratz; H Mykkänen; A C Ouwehand; R Juvonen; S Salminen; H El-Nezami
Journal:  Appl Environ Microbiol       Date:  2004-10       Impact factor: 4.792

8.  The Effects of Supplementation with Probiotic on Biomarkers of Oxidative Stress in Adult Subjects: a Systematic Review and Meta-analysis of Randomized Trials.

Authors:  Behzad Zamani; Ali Sheikhi; Nazli Namazi; Bagher Larijani; Leila Azadbakht
Journal:  Probiotics Antimicrob Proteins       Date:  2020-03       Impact factor: 4.609

9.  Effects of the viability of Lactobacillus rhamnosus GG on rotavirus infection in neonatal rats.

Authors:  Hanna Ventola; Liisa Lehtoranta; Mari Madetoja; Marja-Leena Simonen-Tikka; Leena Maunula; Merja Roivainen; Riitta Korpela; Reetta Holma
Journal:  World J Gastroenterol       Date:  2012-11-07       Impact factor: 5.742

10.  Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum.

Authors:  C Grangette; H Müller-Alouf; D Goudercourt; M C Geoffroy; M Turneer; A Mercenier
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.